Gujarat Fluorochemicals stock
FLUOROCHEM.NSNSEGujarat Fluorochemicals Limited, Basic MaterialsISIN INE09N301011
59Score 59 out of 100, Neutral
Price and trend
81 / 100
Price history
+30% in one yearThe chart shows daily closes over 7 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 23% above it.
Since June 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Overheated: the price has risen very quickly lately (RSI 79).
The price is at its 52-week high. Largest decline in 7 years: 67% (October 2019 to March 2020).
Chart figures for advanced users
- SMA 50$48.00
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$41.75
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)79
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$31.57
- The lowest closing price of the last twelve months.
- Resistance$51.28
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Gujarat Fluorochemicals Limited belongs to the Chemicals (Specialty) industry (India) and, with a market value of $5.62B, is number 57 of 106 companies in its industry on MEQIRI.
- In fiscal 2026 it reported revenue of $531.02M (up 5.5% year on year) and earnings of $61.43M (up 5.8%).
- For fiscal 2027, analysts expect on average revenue of $712.71M (up 34.2%) and adjusted earnings per share of $0.94 (up 63.4%).
Show more
- MEQIRI Score 59 out of 100 (Neutral): rank 214 of 461 in Basic Materials, median 57.
- The P/E is 77.9 (Chemicals (Specialty) median 22.5, own median of recent years 48.1).
- Our model puts fair value at $16.25, with the price 215% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Analysts expect strong earnings growthUp 32.9% a year through 2029 (estimates from 13 analysts).Growth 53
Weaknesses
- Above fair valuePrice 215% above the fair value of $16.25.Valuation 12
- Richly valuedP/E 77.9, Chemicals (Specialty) median 22.5, own median 48.1.Valuation 12
- Margin fallingOperating margin 16.7%, average of the prior years 38.7% (to 2025).Profitability 58
Its standout strengths are momentum and technical analysis, while fundamentals and valuation hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Significantly overvaluedIn our model the price counts as cheap below $12.50 and expensive above $23.22 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $17.72 (cash-flow model) and $14.79 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 13%. At 14% the fair value would be $14.74, at 12% it would be $18.38.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (22.5).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 20.3% on the twelve months before. Revenue has grown solidly since 2018, at about 3% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 66%, operating 17%, net 12%.
Debt & balance sheet
latest quarterLow debt, and interest is adequately covered.
Earnings
- Next earnings
- 9 Feb 2027in 88 days
- Last reported
- 3 Nov 2026EPS reported $0.24 (expected $0.24)in line with expectations
Analyst estimates
Earnings estimates have barely changed since 3 Nov 2026.
- Earnings per share
- $0.94−1.8%
- Revenue
- $712.71M+1.0%
- Earnings per share
- $1.23−1.1%
- Revenue
- $908.76M+2.0%
MEQIRI has stored the estimates since 3 Nov 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Gujarat Fluorochemicals
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 59
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Berger Paints IndiaBERGEPAINT.NS $5.94B68
- Kingboard Holdings0148.HK $5.87B51
- Inner Mongolia Junzheng Energy & Chemical Group601216.SS $5.8B52
- Hubei Feilihua Quartz Glass300395.SZ $5.62B55
- BalchemBCPC $5.49B72
- Navin Fluorine InternationalNAVINFLUOR.NS $5.44B79
- Sumitomo Chemical4005.T $5.42B54
- Zhejiang Longsheng Group600352.SS $5.38B55
ETFs that hold Gujarat Fluorochemicals
Held by 11 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares MSCI EM Small Cap UCITS ETFEUNI | 0.10% | 0.74% | €279.38M |
| Vanguard FTSE Emerging Markets UCITS ETF (USD) AccumulatingVFEA | 0.02% | 0.17% | €5.24B |
| iShares Core MSCI EM IMI UCITS ETFIS3N | 0.01% | 0.18% | €37.98B |
Show 5 more
| iShares MSCI EM IMI Screened UCITS ETF USD (Acc)AYEM | 0.01% | 0.18% | €5.26B |
| Amundi Prime All Country World UCITS ETF AccWEBN | 0.00% | 0.07% | €8.95B |
| Vanguard FTSE All-World UCITS ETF (USD) AccumulatingVWCE | 0.00% | 0.14% | €79.59B |
| Vanguard ESG Global All Cap UCITS ETF (USD) AccumulatingV3AA | 0.00% | 0.24% | €1.69B |
| Vanguard FTSE Global All-Cap UCITS ETF Accum USDVGLA | 0.00% | 0.07% | €3.9B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 May 2024)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.